Two features set the pace observed in trials: Long half-life
This blend is studied for its potential to support cellular repair, tissue recovery, reduced inflammation, and enhanced systemic resilience through angiogenic, cytoprotective, and regenerative pathways
This leads to the release and subsequent cytoplasmic translocation of p53, which in turn activates a transcription-independent pro-apoptotic pathway, facilitating the selective clearance of senescent cells (Kong et al., 2025
Complete Medical History: Fill out a brief medical history form
This analysis, updated with all GLP-1RA CVOT completed to date, supports the hypothesis that achieving HbA1c lowering with these distinct drugs might be critical for cerebrovascular events rather than MI and CV death risk reduction